C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2011
08/25/2011	US20110207608 Transcriptional and post-transcription regulation of transcription factor for drought resistance
08/25/2011	US20110207226 Non-integrating lenti/adeno-associated virus hybrid vector system
08/25/2011	US20110207225 Methods and Systems for Manipulating Particles Using a Fluidized Bed
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110207223 Methods of generating alphavirus particles
08/25/2011	US20110207222 Methods and Systems For Manipulating Particles Using a Fluidized Bed
08/25/2011	US20110207221 Targeted genomic modification with partially single-stranded donor molecules
08/25/2011	US20110207217 Modulation of Gene Expression by Oligomers Targeted to Chromosomal DNA
08/25/2011	US20110207212 T1r taste receptors and genes encoding same
08/25/2011	US20110207211 Expression of immunoglobulin-cytokine fusion proteins in malignant b cells
08/25/2011	US20110207210 Isolated or synthesized Rhopalosiphum padi virus polynucleotides having a promotor activity
08/25/2011	US20110207201 Alpha-amylase mutants
08/25/2011	US20110207197 Method to inhibit ribonuclease dicer, ribonuclease dicer inhibitor, and use of rna aptamers as ribonuclease dicer inhibitors
08/25/2011	US20110207186 Isoforms of Pig Liver Esterase
08/25/2011	US20110207181 Isomaltulose synthases, polynucleotides encoding them and uses therefor
08/25/2011	US20110207173 Self-Replicating Vector Lacking An Antibiotic-Resistance Gene
08/25/2011	US20110207133 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds
08/25/2011	US20110207124 Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism
08/25/2011	US20110207121 Sample processing device for pretreatment and thermal cycling
08/25/2011	US20110207117 Generation of production strains that efficiently express nuclear transgenes
08/25/2011	US20110206759 Ccr7 ligand delivery and co-delivery in immunotherapy
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206730 Dengue Chimeric Viruses
08/25/2011	US20110206728 Dna vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
08/25/2011	US20110206724 Hepatitis virus core proteins as vaccine platforms and methods of use thereof
08/25/2011	US20110206719 Immunostimulatory oligoribonucleotides
08/25/2011	US20110206710 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
08/25/2011	US20110206700 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
08/25/2011	US20110206688 Enhancing Vessel Lesion Homing and Repair Potential of Stem Cells
08/25/2011	US20110206685 Screening assays for inhibitors of a staphylococcus aureus siderophore
08/25/2011	US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011	US20110206681 Binding molecules to the human ox40 receptor
08/25/2011	US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
08/25/2011	US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization
08/25/2011	US20110206673 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206663 Anti-Interferon-Alpha Antibodies
08/25/2011	US20110206655 Fviii-independent fix-mutant proteins for hemophilia a treatment
08/25/2011	US20110206641 Stress tolerant bifidobacteria
08/25/2011	US20110206616 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
08/25/2011	US20110206615 Probe reagent for measuring oxidative stress
08/25/2011	DE102010009445A1 Expression vector comprising promoter, interfaces to insert use-specific gene sequence and genetic information expressing enzyme, useful to express peptide-inhibited small interfering RNA cleaving enzyme, preferably protease or peptidase
08/25/2011	DE102007006008B4 Verfahren und Kit zur Isolierung von Plasmid DNA A method and kit for the isolation of plasmid DNA
08/25/2011	CA2790506A1 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1
08/25/2011	CA2790426A1 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
08/25/2011	CA2790329A1 Fibronectin based scaffold domain proteins that bind il-23
08/25/2011	CA2790290A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790289A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790276A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790232A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790228A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790200A1 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
08/25/2011	CA2790029A1 Axmi221z, axmi222z, axmi223z, axmi224z, and axmi225z delta-endotoxin genes and methods for their use
08/25/2011	CA2789945A1 Universal virus-like particle (vlp) influenza vaccines
08/25/2011	CA2789849A1 Complexes of an3-interacting proteins and their use for plant growth promotion
08/25/2011	CA2789774A1 Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells
08/25/2011	CA2789456A1 Assay for detecting closely-related serotypes of human papillomavirus (hpv)
08/25/2011	CA2789337A1 Hsa-related compositions and methods of use
08/25/2011	CA2789244A1 Rage fusion protein compositions and methods of use
08/25/2011	CA2788842A1 Improving activity of fe-s cluster requiring proteins
08/25/2011	CA2787950A1 Nucleic acid extraction from complex matrices
08/25/2011	CA2784211A1 Neuregulin antagonists and use thereof in treating cancer
08/24/2011	EP2360478A1 Molecular targets and compounds and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
08/24/2011	EP2360474A2 Methods and means for treatment of osteoarthritis
08/24/2011	EP2360473A1 Compositions and methods for analyzing protein interactions
08/24/2011	EP2360276A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
08/24/2011	EP2360275A1 Oligonucleotide identifiers
08/24/2011	EP2360274A1 Compositions and processes for analyte detection; quantification and amplification
08/24/2011	EP2360273A1 Compositions and processes for analyte detection; quantification and amplification
08/24/2011	EP2360272A1 Method to generate or determine nucleic acid tags corresponding to the terminal ends of DNA molecules using sequence analysis of gene expression (terminal SAGE)
08/24/2011	EP2360267A2 Yeast cell surface display of proteins and uses thereof
08/24/2011	EP2360266A2 Yeast cell surface display of proteins and uses thereof
08/24/2011	EP2360265A2 Yeast cell surface display of proteins and uses thereof
08/24/2011	EP2360264A2 Yeast cell surface display of proteins and uses thereof
08/24/2011	EP2360261A1 Collagen producing plants and methods of generating and using same
08/24/2011	EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis
08/24/2011	EP2360259A2 Promyostatin peptides and methods of using same
08/24/2011	EP2360258A2 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
08/24/2011	EP2360257A2 Hepatitis B virus (HBV) variants
08/24/2011	EP2360256A1 Method for isolation of soluble polypeptides
08/24/2011	EP2360255A1 Method for isolation of soluble polypeptides
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011	EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011	EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing
08/24/2011	EP2360250A2 siRNA for treatment of blood vessels
08/24/2011	EP2360249A1 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
08/24/2011	EP2360247A1 Subtilase variants
08/24/2011	EP2360244A1 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
08/24/2011	EP2360243A1 Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
08/24/2011	EP2360186A1 Anti-P-selectin antibodies
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2360176A2 Hybrid and tandem expression of neisserial derived proteins
08/24/2011	EP2360169A2 PSMA antibodies
08/24/2011	EP2360168A1 Flavivirus fusion inhibitors
08/24/2011	EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor
08/24/2011	EP2359868A1 Vector encoding human globulin gene and use thereof in treatment of hemoglobinopathies
08/24/2011	EP2359867A1 Method of increasing the function of an AAV vector
08/24/2011	EP2359866A1 Method of increasing the function of an AAV vector
08/24/2011	EP2359865A1 Method of increasing the function of an AAV vector

1 ... 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 ... 4023